# Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

> **NCT00580385** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 763 (actual)

## Conditions studied

- Osteosarcoma

## Interventions

- **OTHER:** Tissue Procurement

## Key facts

- **NCT ID:** NCT00580385
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 1997-08
- **Primary completion:** 2027-08
- **Final completion:** 2027-08
- **Target enrollment:** 763 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580385, "Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00580385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*